All the news

Showing 10 of 76 articles from: Treatment outcomes

Get an RSS feed of these articles

Show

Do direct acting antivirals cure chronic hepatitis C?

BMJ / 18 May 2018
Does portal hypertension always improve after hepatitis C cure?

Keith Alcorn / 10 May 2018

Although portal hypertension improves in the majority of people with hepatitis C and cirrhosis after hepatitis C is cured, not all people experience improvement, and oesophageal varices may continue to ...
Fewer non-liver cancers in people treated with DAAs compared to the interferon era

Keith Alcorn / 02 May 2018

The risk of non-liver cancer is lower in people treated with direct-acting antivirals (DAAs) than in those treated with interferon and is probably an effect of the improved cure rate ...
SVR after HCV therapy reduces extrahepatic mortality, manifestations

Healio Hepatology / 01 May 2018
Curing hepatitis C reduces deaths and liver disease

Keith Alcorn / 17 April 2018

Curing hepatitis C infection significantly reduces deaths from liver disease and reduces the incidence of decompensation, two large prospective studies from Italy and Scotland show. The findings were presented on ...
The VA Will Eliminate Hepatitis C In Veterans By Year-end

Forbes / 02 March 2018
Ethnic disparities evaporate with DAA treatment of hepatitis C infections

ModernMedicine / 06 February 2018
Low skeletal muscle mass improves after successful HCV treatment

Healio Hepatology / 22 November 2017
Fatty Liver Common After Direct-Acting Antivirals for Hep C

Medscape (requires free registration) / 01 November 2017
Curing hepatitis C with DAAs linked to 71% reduction in liver cancer

Liz Highleyman / 30 October 2017

People who achieved a sustained response to hepatitis C treatment lowered their risk of hepatocellular carcinoma by around 70%, regardless of whether they were treated with new direct-acting antivirals (DAAs) or older interferon-based therapy, ...